What Researchers Did
Researchers reviewed the current applications and possible mechanisms of Hyperbaric Oxygenation Therapy (HBOT).
What They Found
They found that Hyperbaric Oxygenation Therapy (HBOT) shows therapeutic efficacy for conditions like angiogenesis, tissue ischemia, nerve system diseases, diabetic complications, malignancies, carbon monoxide poisoning, and chronic radiation-induced injury. However, HBOT also carries risks including oxidative stress injury, DNA damage, cellular metabolic changes, coagulation activation, endothelial dysfunction, acute neurotoxicity, and pulmonary toxicity.
What This Means for Canadian Patients
Canadian patients considering Hyperbaric Oxygenation Therapy (HBOT) should discuss its potential benefits for conditions like tissue ischemia or diabetic complications with their healthcare provider. It is crucial to also understand the associated risks, such as oxidative stress or neurotoxicity, to make an informed decision about this adjunctive treatment.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The review acknowledges that the overall applicability and validity of Hyperbaric Oxygenation Therapy for clinical treatment remain controversial.